2 options
FDA Regulation of Follow-On Biologics.
- Format:
- Book
- Government document
- Author/Creator:
- Library of Congress. Congressional Research Service.
- Language:
- English
- Subjects (All):
- Medical laws and legislation.
- Physical Description:
- 1 online resource (19 pages, digital, PDF file)
- Place of Publication:
- [Place of publication not identified] : [publisher not identified], 2008.
- System Details:
- text file
- Summary:
- Discusses proposal to create FDA pathway for approval of follow-on biologics, which are medical preparations made from living organisms. Provides introduction to relevant law, FDA regulatory framework, and scientific challenges for FDA in considering approval of follow-on biologics; and describes proposed legislation.
- Notes:
- Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Dec. 2010). Reuse except for individual research requires license from ProQuest, LLC.
- CRS Report.
- Other Format:
- Microfiche version: Library of Congress. Congressional Research Service. FDA Regulation of Follow-On Biologics
- Access Restriction:
- Restricted for use by site license.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.